Diabetic retinopathy treatment is selected by the retinal complication
Macular edema may require injections, focal treatment or observation; proliferative disease may need scatter laser, injections or surgery for bleeding and traction.
Eye treatment does not replace control of blood glucose, blood pressure, lipids, pregnancy risk and kidney disease. Both eyes may progress differently.
One injection or laser session may not complete care; define the review interval and criteria for switching or adding treatment.
Who may be considered?
Specialist review may help when the diagnosis, symptoms and previous treatment create a focused question about diabetic retinopathy treatment.
- Center-involving diabetic macular edema affecting vision.
- Proliferative retinopathy with abnormal new vessels.
- Vitreous hemorrhage or traction threatening the macula.
- A patient needing treatment before cataract surgery or pregnancy-related progression.
What the specialist team must confirm
Review dilated examination, OCT, retinal photographs, angiography when indicated, visual acuity, prior injections and laser, glucose control, blood pressure, kidney disease and pregnancy status.
Key points for this treatment
From retinal phenotype to repeated response assessment
The goal may be to improve central vision, prevent severe loss, clear bleeding or stabilize the retina before another eye operation.
Response and recurrence guide the schedule
OCT and visual acuity are repeated after injections; laser effect and new vessels are checked clinically.
Long-term monitoring continues even when vision feels stable because progression can occur without early symptoms.
Risks, limits and realistic expectations
Risks vary by treatment and include infection after injection, pressure rise, peripheral or night-vision reduction after laser, bleeding, retinal detachment, cataract and incomplete visual recovery.
Sudden floaters, flashes, a curtain shadow, rapid visual decline, severe pain or increasing redness after treatment requires urgent eye care.